These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
194 related articles for article (PubMed ID: 25596581)
21. Update on the diagnosis and management of neurocysticercosis. Takayanagui OM; Haes TM Arq Neuropsiquiatr; 2022 May; 80(5 Suppl 1):296-306. PubMed ID: 35976305 [TBL] [Abstract][Full Text] [Related]
22. Multilevel intramedullary spinal neurocysticercosis with eosinophilic meningitis. Torabi AM; Quiceno M; Mendelsohn DB; Powell CM Arch Neurol; 2004 May; 61(5):770-2. PubMed ID: 15148157 [TBL] [Abstract][Full Text] [Related]
23. Outcomes of medical treatment of neurocysticercosis: a study of 65 cases in Cheju Island, Korea. Kim SK; Wang KC; Paek SH; Hong KS; Cho BK Surg Neurol; 1999 Dec; 52(6):563-9. PubMed ID: 10660021 [TBL] [Abstract][Full Text] [Related]
24. Albendazole and praziquantel treatment in neurocysticercosis of the fourth ventricle. Proaño JV; Madrazo I; García L; García-Torres E; Correa D J Neurosurg; 1997 Jul; 87(1):29-33. PubMed ID: 9202261 [TBL] [Abstract][Full Text] [Related]
27. Role of antiparasitic therapy for seizures and resolution of lesions in neurocysticercosis patients: an 8 year randomised study. Das K; Mondal GP; Banerjee M; Mukherjee BB; Singh OP J Clin Neurosci; 2007 Dec; 14(12):1172-7. PubMed ID: 17964789 [TBL] [Abstract][Full Text] [Related]
28. Neurocysticercosis: surgical treatment of an autochthonous case in a non-endemic region. Bruschi F; Giangaspero F; Castagna M; Becherini F; Filice ME; Vannozzi R; Cantini R Pathologica; 2006 Aug; 98(4):229-31. PubMed ID: 17175791 [TBL] [Abstract][Full Text] [Related]
29. Routine drug and food interactions during antihelminthic treatment of neurocysticercosis: a reason for the variable efficacy of albendazole and praziquantel? Romo ML; Carpio A; Kelvin EA J Clin Pharmacol; 2014 Apr; 54(4):361-7. PubMed ID: 24443292 [TBL] [Abstract][Full Text] [Related]
30. Intramedullary spinal neurocysticercosis treated successfully with medical therapy. Ahmed S; Paul SP J Egypt Soc Parasitol; 2014 Dec; 44(3):661-4. PubMed ID: 25643507 [TBL] [Abstract][Full Text] [Related]
32. Neurocysticercosis: migration and proliferation of cysticercus in a CSF valve. Djientcheu VD; Zona G; Rilliet B Br J Neurosurg; 2000 Apr; 14(2):135-7. PubMed ID: 10889887 [TBL] [Abstract][Full Text] [Related]
33. [Experience in treating cysticercosis of the brain with azinox]. Tumol'skaia NI; Glazunova TI; Dobzhanskiĭ NV; Sushurov EB; Stankov DS Med Parazitol (Mosk); 2002; (4):44-6. PubMed ID: 12557589 [TBL] [Abstract][Full Text] [Related]
35. Neurocysticercosis. Lev N; Michowiz S; Inbar E; Coire CI; Pitlik S; Melamed E Isr Med Assoc J; 2002 Jan; 4(1):65-6. PubMed ID: 11802316 [No Abstract] [Full Text] [Related]
36. Neurocysticercosis in pregnancy: a case initially diagnosed as eclampsia. Suarez VR; Iannucci TA Obstet Gynecol; 1999 May; 93(5 Pt 2):816-8. PubMed ID: 10912405 [TBL] [Abstract][Full Text] [Related]
37. Isolated spinal neurocysticercosis with clinical pleomorphism. Kasliwal MK; Gupta DK; Suri V; Sharma BS; Garg A Turk Neurosurg; 2008 Jul; 18(3):294-7. PubMed ID: 18814121 [TBL] [Abstract][Full Text] [Related]
38. Neurocysticercosis: an unusual cause of seizure in the New Zealand setting. Pybus M; Heron P J Paediatr Child Health; 2012 Mar; 48(3):E119-21. PubMed ID: 21276113 [TBL] [Abstract][Full Text] [Related]
39. Pharmacokinetic variability of anthelmintics: implications for the treatment of neurocysticercosis. Jung-Cook H Expert Rev Clin Pharmacol; 2012 Jan; 5(1):21-30. PubMed ID: 22142156 [TBL] [Abstract][Full Text] [Related]